Literature DB >> 17406276

Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.

Mohammed Amarzguioui1, Patric Lundberg, Edouard Cantin, James Hagstrom, Mark A Behlke, John J Rossi.   

Abstract

RNA interference is a powerful tool for target-specific knockdown of gene expression. The triggers for this process are duplex small interfering RNAs (siRNAs) of 21-25 nt with 2-bp 3' overhangs produced in cells by the RNase III family member Dicer. We have observed that short RNAs that are long enough to serve as Dicer substrates (D-siRNA) can often evoke more potent RNA interference than the corresponding 21-nt siRNAs; this is probably a consequence of the physical handoff of the Dicer-produced siRNAs to the RNA-induced silencing complex. Here we describe the design parameters for D-siRNAs and a protocol for in vitro and in vivo intraperitoneal delivery of D-siRNAs and siRNAs to macrophages. siRNA delivery and transfection and analysis of macrophages in vivo can be accomplished within 36 h.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406276     DOI: 10.1038/nprot.2006.72

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  48 in total

1.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents.

Authors:  Marta Olejniczak; Paulina Galka-Marciniak; Katarzyna Polak; Andrzej Fligier; Wlodzimierz J Krzyzosiak
Journal:  RNA       Date:  2012-03-12       Impact factor: 4.942

2.  Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia.

Authors:  Martin Schaller; Katherina Zakikhany; Julian R Naglik; Günther Weindl; Bernhard Hube
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  RNA interference: A futuristic tool and its therapeutic applications.

Authors:  Anghesom Ambesajir; Atul Kaushik; Jeevan J Kaushik; Sham T Petros
Journal:  Saudi J Biol Sci       Date:  2012-08-17       Impact factor: 4.219

Review 4.  RNAi mechanisms and applications.

Authors:  Daniel Kim; John Rossi
Journal:  Biotechniques       Date:  2008-04       Impact factor: 1.993

5.  Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity.

Authors:  Qing Ge; Heini Ilves; Anne Dallas; Pavan Kumar; Joshua Shorenstein; Sergei A Kazakov; Brian H Johnston
Journal:  RNA       Date:  2009-12-01       Impact factor: 4.942

6.  Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.

Authors:  Yuelong Ma; Claudia M Kowolik; Piotr M Swiderski; Marcin Kortylewski; Hua Yu; David A Horne; Richard Jove; Otavia L Caballero; Andrew J G Simpson; Fook-Thean Lee; Vinochani Pillay; Andrew M Scott
Journal:  ACS Chem Biol       Date:  2011-07-26       Impact factor: 5.100

7.  Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.

Authors:  Lichen Yin; Ziyuan Song; Qiuhao Qu; Kyung Hoon Kim; Nan Zheng; Catherine Yao; Isthier Chaudhury; Haoyu Tang; Nathan P Gabrielson; Fatih M Uckun; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-04-22       Impact factor: 15.336

8.  Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.

Authors:  Kenneth A Howard; Søren R Paludan; Mark A Behlke; Flemming Besenbacher; Bent Deleuran; Jørgen Kjems
Journal:  Mol Ther       Date:  2008-09-30       Impact factor: 11.454

Review 9.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

10.  Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.

Authors:  Jiehua Zhou; Piotr Swiderski; Haitang Li; Jane Zhang; C Preston Neff; Ramesh Akkina; John J Rossi
Journal:  Nucleic Acids Res       Date:  2009-03-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.